Cargando…
Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
Head and neck squamous cell carcinoma (HNSCC) is one of the most aggressive malignancies with complex phenotypic, etiological, biological, and clinical heterogeneities. Previous studies have proposed different clinically relevant subtypes of HNSCC, but little is known about its corresponding prognos...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476885/ https://www.ncbi.nlm.nih.gov/pubmed/34595167 http://dx.doi.org/10.3389/fcell.2021.711348 |
_version_ | 1784575716883431424 |
---|---|
author | Zhang, Pei Li, Shue Zhang, Tingting Cui, Fengzhen Shi, Ji-Hua Zhao, Faming Sheng, Xia |
author_facet | Zhang, Pei Li, Shue Zhang, Tingting Cui, Fengzhen Shi, Ji-Hua Zhao, Faming Sheng, Xia |
author_sort | Zhang, Pei |
collection | PubMed |
description | Head and neck squamous cell carcinoma (HNSCC) is one of the most aggressive malignancies with complex phenotypic, etiological, biological, and clinical heterogeneities. Previous studies have proposed different clinically relevant subtypes of HNSCC, but little is known about its corresponding prognosis or suitable treatment strategy. Here, we identified 101 core genes from three prognostic pathways, including mTORC1 signaling, unfold protein response, and UV response UP, in 124 pairs of tumor and matched normal tissues of HNSCC. Moreover, we identified three robust subtypes associated with distinct molecular characteristics and clinical outcomes using consensus clustering based on the gene expression profiles of 944 HNSCC patients from four independent datasets. We then integrated the genomic information of The Cancer Genome Atlas (TCGA) HNSCC cohort to comprehensively evaluate the molecular features of different subtypes and screen for potentially effective therapeutic agents. Cluster 1 had more arrested oncogenic signaling, the highest immune cell infiltration, the highest immunotherapy and chemotherapeutic responsiveness, and the best prognosis. By contrast, Cluster 3 showed more activated oncogenic signaling, the lowest immune cell infiltration, the lowest immunotherapy and chemotherapy responsiveness, and the worst prognosis. Our findings corroborate the molecular diversity of HNSCC tumors and provide a novel classification strategy that may guide for prognosis and treatment allocation. |
format | Online Article Text |
id | pubmed-8476885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84768852021-09-29 Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness Zhang, Pei Li, Shue Zhang, Tingting Cui, Fengzhen Shi, Ji-Hua Zhao, Faming Sheng, Xia Front Cell Dev Biol Cell and Developmental Biology Head and neck squamous cell carcinoma (HNSCC) is one of the most aggressive malignancies with complex phenotypic, etiological, biological, and clinical heterogeneities. Previous studies have proposed different clinically relevant subtypes of HNSCC, but little is known about its corresponding prognosis or suitable treatment strategy. Here, we identified 101 core genes from three prognostic pathways, including mTORC1 signaling, unfold protein response, and UV response UP, in 124 pairs of tumor and matched normal tissues of HNSCC. Moreover, we identified three robust subtypes associated with distinct molecular characteristics and clinical outcomes using consensus clustering based on the gene expression profiles of 944 HNSCC patients from four independent datasets. We then integrated the genomic information of The Cancer Genome Atlas (TCGA) HNSCC cohort to comprehensively evaluate the molecular features of different subtypes and screen for potentially effective therapeutic agents. Cluster 1 had more arrested oncogenic signaling, the highest immune cell infiltration, the highest immunotherapy and chemotherapeutic responsiveness, and the best prognosis. By contrast, Cluster 3 showed more activated oncogenic signaling, the lowest immune cell infiltration, the lowest immunotherapy and chemotherapy responsiveness, and the worst prognosis. Our findings corroborate the molecular diversity of HNSCC tumors and provide a novel classification strategy that may guide for prognosis and treatment allocation. Frontiers Media S.A. 2021-09-14 /pmc/articles/PMC8476885/ /pubmed/34595167 http://dx.doi.org/10.3389/fcell.2021.711348 Text en Copyright © 2021 Zhang, Li, Zhang, Cui, Shi, Zhao and Sheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Zhang, Pei Li, Shue Zhang, Tingting Cui, Fengzhen Shi, Ji-Hua Zhao, Faming Sheng, Xia Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness |
title | Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness |
title_full | Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness |
title_fullStr | Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness |
title_full_unstemmed | Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness |
title_short | Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness |
title_sort | characterization of molecular subtypes in head and neck squamous cell carcinoma with distinct prognosis and treatment responsiveness |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476885/ https://www.ncbi.nlm.nih.gov/pubmed/34595167 http://dx.doi.org/10.3389/fcell.2021.711348 |
work_keys_str_mv | AT zhangpei characterizationofmolecularsubtypesinheadandnecksquamouscellcarcinomawithdistinctprognosisandtreatmentresponsiveness AT lishue characterizationofmolecularsubtypesinheadandnecksquamouscellcarcinomawithdistinctprognosisandtreatmentresponsiveness AT zhangtingting characterizationofmolecularsubtypesinheadandnecksquamouscellcarcinomawithdistinctprognosisandtreatmentresponsiveness AT cuifengzhen characterizationofmolecularsubtypesinheadandnecksquamouscellcarcinomawithdistinctprognosisandtreatmentresponsiveness AT shijihua characterizationofmolecularsubtypesinheadandnecksquamouscellcarcinomawithdistinctprognosisandtreatmentresponsiveness AT zhaofaming characterizationofmolecularsubtypesinheadandnecksquamouscellcarcinomawithdistinctprognosisandtreatmentresponsiveness AT shengxia characterizationofmolecularsubtypesinheadandnecksquamouscellcarcinomawithdistinctprognosisandtreatmentresponsiveness |